Transcatheter arterial chemoembolization after stopping sorafenib therapy for advanced hepatocellular carcinoma

Targeted therapy is currently the standard treatment for advanced hepatocellular carcinoma (HCC), but an effective treatment after the discontinuation of sorafenib therapy remains uncertain. We aim to investigate the survival benefits of transcatheter arterial chemoembolization (TACE) after stopping...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Huang, Yao-Kuang, Yen, Chieh-Ling, Shiu, Sz-Iuan, Lee, Shou-Wu, Chang, Pi-Yi, Yeh, Hong-Zen, Lee, Teng-Yu
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5708733/
https://ncbi.nlm.nih.gov/pubmed/29190692
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0188999
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados